Adaptive Biotechnologies Corporation
NPI 1508105024 · Clinical Medical Laboratory · Seattle, WA
Enrolled with Medicare as Part B Supplier - Independent Clinical Laboratory · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Adaptive Biotechnologies Corporation is a Clinical Medical Laboratory organization in Seattle, WA (NPI 1508105024).
Provider details
- NPI number
- 1508105024
- Entity type
- Organization
- Primary specialty
- Clinical Medical LaboratoryLaboratories
- Organization subpart
- No
- Authorized official
- Chad Robins, Ceo, President, Co-Founder(888) 552-8988
- License
- 50D2046518 (WA)
Specialties & taxonomies
Laboratories
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
13 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
5,123 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Molecular Pathology Procedure81479 | 5,123 | $7,099 |
Typical Medicare-allowed amounts for these services range $7,099–$7,099 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
Practice location
Mailing address
Registry dates
- Enumerated
- 2013-02-04
- Last updated
- 2025-03-31
- Certified
- 2025-03-31
Frequently asked questions
- What is Adaptive Biotechnologies Corporation's NPI number?
- Adaptive Biotechnologies Corporation's National Provider Identifier (NPI) is 1508105024, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What type of organization is Adaptive Biotechnologies Corporation?
- Adaptive Biotechnologies Corporation is classified in the NPPES registry as Clinical Medical Laboratory (Laboratories).
- Where is Adaptive Biotechnologies Corporation located?
- Adaptive Biotechnologies Corporation's practice location on file with NPPES is 1165 Eastlake Ave E, Seattle, WA 98109-4456.
- What is Adaptive Biotechnologies Corporation's phone number?
- The practice phone number listed in the NPPES registry for Adaptive Biotechnologies Corporation is (888) 552-8988.
- Does Adaptive Biotechnologies Corporation accept Medicare?
- Adaptive Biotechnologies Corporation is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Who is the authorized official for Adaptive Biotechnologies Corporation?
- The authorized official listed on Adaptive Biotechnologies Corporation's NPPES record is Chad Robins, Ceo, President, Co-Founder. The authorized official registers and maintains the organization's NPI and is not necessarily its owner.
- Is Adaptive Biotechnologies Corporation's NPI active?
- Yes — Adaptive Biotechnologies Corporation's NPI (1508105024) is active in the NPPES registry as of the last update on 2025-03-31.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.